Despite a difficult economic environment, Switzerland’s pharmaceutical industry has continued to expand in the past two years and today accounts for 25 percent of total industrial value added. As such, the pharmaceutical sector is a major pillar of Switzerland’s export industry. With its high average real growth in value added of 7.2 percent per annum, the sector has made a significant contribution to the growth of Switzerland’s economy over the past decade. This expansion has also led to an increase in the number of jobs by more than 12,000 over the last ten years, bringing the total number of people employed in the industry to 45,500. Businesses in other sectors also benefit from the success of Switzerland’s pharmaceutical companies. As shown by a macroeconomic impact analysis, 2016 saw an additional value added of 20.7 billion Swiss francs generated in other sectors due to the economic activity of the pharmaceutical industry. This accounted for around 138,000 jobs in these sectors.